Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
October 28, 2016 08:00 ET
|
Helocyte, Inc.; City of Hope
Triplex Demonstrated Favorable Safety and Immunogenicity at Multiple Dose Levels in Healthy Volunteers Data Published in Blood Support Ongoing Phase 2 Trial of Triplex in Allogeneic...
Helocyte Announces Corporate and Clinical Milestones
April 21, 2016 07:00 ET
|
Helocyte, Inc.
Frank Taffy Appointed President and Chief Executive OfficerLead Immunotherapies PepVax and Triplex Advanced into Phase 2 Triplex Phase 1 Data Presented at ASHPepVax Phase 1b Data Published in...